Surgical Robotics Industry Awards 2026 Announces Winners Across Six Categories

Moon Surgical, SS Innovations International, Microbot Medical and other recipients recognised through global community voting

Surgical Robotics Technology has announced the recipients of the Surgical Robotics Industry Awards 2026, recognising achievements by individuals, companies, healthcare providers and technologies within the surgical robotics industry.

According to the organisers, winners are selected each year through voting by the global surgical robotics community. Since the awards were launched, more than 50,000 votes have been cast, making the programme a form of peer recognition within the sector.

Industry Leadership

Winner: Steve Bell – Expert in MedTech & Surgical Robotics

Steve Bell has more than 30 years of experience in MedTech, including over a decade leading multiple startup divisions at Johnson & Johnson. He also spent 20 years building and scaling MedTech startups globally. During his career, he has raised more than $1.5 billion in capital and contributed to the growth of Europe’s largest medical device unicorn. He currently provides advisory support to several surgical robotics companies.

Steve Bell said:

“I am thrilled for this recognition within the surgical robotics industry. For me one of the most important things is that you, my peers, vote on this. It gives me even more encouragement to keep producing content for the community. Many thanks to Surgical Robotics Technology for keeping these awards alive and real."

Innovative Start-up

Winner: Microbot Medical

Microbot Medical Inc. (NASDAQ: MBOT) is a commercial-stage medical device company focused on endovascular robotic technology. Its LIBERTY® Endovascular Robotic System is described as the world's first FDA-cleared single-use, remotely operated robotic solution designed for endovascular procedures.

Harel Gadot, CEO, President, and Chairman of the Board of Directors at Microbot Medical Inc., said:

“On behalf of our entire company, I am honored that we have been recognized with the Innovative Start-up Award for the 2026 Surgical Robotic Awards. This award is more than a milestone; it is a powerful affirmation of our mission to redefine endovascular robotics by establishing a new category of surgical robotics, and to expand what is possible for all stakeholders, starting with clinicians and their patients.

From day one, we set out to challenge conventional thinking, build practical and accessible technology, and bring meaningful innovation to the front lines of healthcare. I am deeply grateful to our employees, clinical partners, shareholders, and supporters whose commitment and belief in our journey have made this achievement possible. As we look ahead, we will continue to lead with purpose, execute with discipline, and deliver solutions that will help shape the future of healthcare.”

Outstanding Company

Winner: SS Innovations International

SS Innovations International was recognised for its work in expanding access to robotic surgery through the SSi Mantra Surgical Robotic System. The company reported surpassing 10,500 procedures performed globally with the platform while securing additional regulatory approvals in Colombia, Oman, Sri Lanka and Kenya. It also continues development of its SSI MantraM mobile telesurgery platform for remote training, demonstrations and surgical connectivity.

Sudhir Srivastava, MD, Founder, Chairman and CEO of SS Innovations International, said:

"It really gives us a tremendous pride and pleasure that we were chosen to be the winner.

And a lot of this credit actually goes to our wonderful team of engineers, our support staff, and also the end users who have trusted us with this technology that is very advanced.

So once again, I want to thank the people who voted for us for this award."

Groundbreaking Technology

Winner: The Sentante Robotic System – Sentante

The Sentante Robotic System is a teleoperated endovascular robotic platform designed to enable remote vascular interventions using standard guidewires and catheters. The system provides haptic force feedback and real-time robotic control during minimally invasive endovascular procedures. Its commercial version is CE-marked for peripheral interventions, while the next-generation system for ischemic stroke treatment has received FDA Breakthrough Device Designation and has been accepted into the FDA Total Product Life Cycle (TAP) Advisory Program.

Edvardas Satkauskas, CEO of Sentante, said:

“Winning the Groundbreaking Technology award is a huge honor for the entire Sentante team. It fuels our passion to keep pushing the limits of endovascular robotics, keeping physicians safe, and ultimately delivering better care to patients.”

Software Innovation

Winner: Maestro Insights – Moon Surgical

Maestro Insights by Moon Surgical is a digital platform that captures and organises procedural and operational data to provide visibility into surgical workflow, operating room coordination and resource utilisation. The platform is designed to support data-driven management of operating room activities.

Anne Osdoit, CEO, Moon Surgical, said:

"Data-driven decision-making is critical in the operating room. The Maestro Insights Platform gives surgeons, staff, and schedulers a new level of visibility into OR operations, empowering them to anticipate and adapt to the day's flow. Recognition for the Insights Platform is a testament to the dedicated teams and surgical partners who helped bring a scalable surgical experience to life."

Outstanding Healthcare Provider

Winner: Cohen Orthopedic

Cohen Orthopedic, led by orthopedic surgeon Dr. Brian Cohen, provides orthopedic care across Chillicothe, Grove City and Columbus. Dr. Cohen has performed more than 3,000 MAKO robotic-assisted hip, knee and revision joint replacement procedures using Stryker’s MAKO SmartRobotics™ platform. The practice is also developing an ambulatory surgery center focused on infection prevention, surgical innovation and patient safety.

Dr. Brian Cohen, Lead Surgeon, Cohen Orthopedic, said:

“It is my honor and a privilege to be named again as Surgical Robotics Industry Outstanding Healthcare Provider for 2026. This recognition is deeply meaningful because it reflects the collective efforts of an extraordinary team dedicated to one purpose: delivering the safest, highest-quality care possible for every patient we serve.

While we are honored to be recognized by the global Surgical Robotics Community, we view this award not as a culmination, but as a milestone along a much larger journey.

This award reinforces our belief that the future of healthcare belongs to organizations willing to challenge convention, embrace innovation, and relentlessly pursue better outcomes for patients.

We are grateful to our patients, our team members, our physician partners, and the Surgical Robotics Community for this recognition. The best chapters of our story are still being written, and we remain committed to advancing the future of healthcare with one guiding principle:

Patients First.”

Carsten Hurasky, Chief Marketing Officer, QNX, said:

"Every year the Surgical Robotic Technology Awards demonstrates exactly how the industry continues to push the boundaries of what modern medicine can achieve. Winners are using technology to impact everything from improving patient outcomes to redefining clinical workflows. As an ongoing partner to these awards, QNX is honoured to recognise and support the innovators who are making surgery safer, smarter, and more precise for patients around the world."

Josef de Pfeiffer, Founder of Surgical Robotics Technology, said:

"Congratulations to all of this year’s winners and finalists. Their achievements reflect the pace of innovation across the surgical robotics sector. We'd also like to thank our partner, QNX, and everyone who participated in the voting process. The level of talent, innovation and commitment across the industry continues to impress."